Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: Hypothetical solutions for neurodevelopmental models and therapeutic alternatives in Down syndrome
applications in DS. Several doses of DYRK1A inhibitors can be tested in the neurodevelopment process of DS-COs and DS-scDYRK1AKO-COs would be used as optimum models for evaluating ... efficient in studies that aim to…

